{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:56:06Z","timestamp":1778504166367,"version":"3.51.4"},"reference-count":32,"publisher":"China Science Publishing & Media Ltd.","issue":"4","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Hospital of Zhengzhou University"}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/abbs\/gmy014","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T12:07:22Z","timestamp":1517227642000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Myeloid-derived suppressor cells suppress CD4 T cell activity and prevent the development of type 2 diabetes"],"prefix":"10.3724","volume":"50","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/diacare.28.9.2130","volume":"28","author":"Roglic G","year":"2005","unstructured":"Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V. The burden of mortality attributable to diabetes. Diabetes Care, 2005, 28: 2130-2135.","journal-title":"Diabetes Care"},{"key":"null","first-page":"12","volume":"51","author":"Botushanov NP","year":"2009","unstructured":"Botushanov NP, Orbetzova MM. Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus. Folia Med, 2009, 51: 12-17.","journal-title":"Folia Med"},{"key":"null","first-page":"274","volume":"101","author":"Association AD","year":"2010","unstructured":"Association AD. Diagnosis and classification of diabetes mellitus. Am Family Physic, 2010, 101:","journal-title":"Am Family Physic"},{"key":"null","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10654-015-0026-5","volume":"30","author":"Chaker L","year":"2015","unstructured":"Chaker L, Falla A, Sj VDL, Muka T, Imo D, Jaspers L, Colpani V. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. Eur J Epidemiol, 2015, 30: 357-395.","journal-title":"Eur J Epidemiol"},{"key":"null","first-page":"147","volume":"36","author":"Sathyapalan T","year":"2011","unstructured":"Sathyapalan T, Atkin SL. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?. Minerva Endocrinol, 2011, 36: 147-156.","journal-title":"Minerva Endocrinol"},{"key":"null","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.mehy.2009.01.028","volume":"72","author":"Li ZZ","year":"2009","unstructured":"Li ZZ, Liu JB, Li L, Jiao L, Chen L. Intensive therapy for diabetes through influence on innate immune system. Med Hypotheses, 2009, 72: 675-676.","journal-title":"Med Hypotheses"},{"key":"null","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","volume":"106","author":"Ehses JA","year":"2009","unstructured":"Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A, 2009, 106: 13998-14003.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"null","first-page":"254","volume":"34","author":"Zhang QL","year":"2012","unstructured":"Zhang QL, Zang SF. Correlation of T lymphocyte subsets with blood glucose level and the first-phase insulin secretion in patients with type 2 diabetes mellitus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2012, 34: 254-257.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"null","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","volume":"40","author":"Pickup JC","year":"1997","unstructured":"Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997, 40:","journal-title":"Diabetologia"},{"key":"null","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4314\/ahs.v16i3.11","volume":"16","author":"Nekoua MP","year":"2016","unstructured":"Nekoua MP, Fachinan R, Atchamou AK, Nouatin O, Amoussou-Guenou D, Amoussou-Guenou MK, Moutairou K. Modulation of immune cells and Th1\/Th2 cytokines in insulin-treated type 2 diabetes mellitus. Afr Health Sci, 2016, 16:","journal-title":"Afr Health Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3727\/000000003108747154","volume":"12","author":"Erices AA","year":"2003","unstructured":"Erices AA, Allers CI, Conget PA, Rojas CV, Minguell JJ. Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant, 2003, 12: 555-561.","journal-title":"Cell Transplant"},{"key":"null","first-page":"219","volume":"18","author":"Hui C","year":"2012","unstructured":"Hui C, Feng W, Zhang X, Shao BS. Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. Mol Vision, 2012, 18: 219-226.","journal-title":"Mol Vision"},{"key":"null","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/imm.12421","volume":"144","author":"Kumar NP","year":"2014","unstructured":"Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB, Babu S. Type 2 diabetes mellitus is associated with altered CD8+ T and NK cell function in pulmonary tuberculosis. Immunology, 2014, 144: 677-686.","journal-title":"Immunology"},{"key":"null","first-page":"2582","volume":"9","author":"Ehiaghe FA","year":"2016","unstructured":"Ehiaghe FA. Some physiochemical changes associated with type 2 diabetes mellitus in Benin City, Nigeria. Int J Biol. Chem Sci, 2016, 9:","journal-title":"Chem Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"Gabrilovich DI","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 2009, 9: 162-174.","journal-title":"Nat Rev Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1158\/1078-0432.CCR-07-0182","volume":"13","author":"Talmadge JE","year":"2007","unstructured":"Talmadge JE. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res, 2007, 13: 5243-5248.","journal-title":"Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"Gabrilovich DI","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived-suppressor cells as regulators of the immune system. Nat Rev Immunol, 2009, 9:","journal-title":"Nat Rev Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","volume":"135","author":"Haile LA","year":"2008","unstructured":"Haile LA, Von WR, Gamrekelashvili J, Kr\u00fcger C, Bachmann O, Westendorf AM, Buer J. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology, 2008, 135: 871-881.","journal-title":"Gastroenterology"},{"key":"null","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","volume":"32","author":"Marigo I","year":"2010","unstructured":"Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S. Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor. Immunity, 2010, 32: 790-802.","journal-title":"Immunity"},{"key":"null","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1172\/JCI41628","volume":"120","author":"Garcia MR","year":"2010","unstructured":"Garcia MR, Ledgerwood L, Yang Y, Xu J, Lal G, Burrell B, Ma G. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest, 2010, 120: 2486-2496.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4314\/ahs.v16i3.11","volume":"16","author":"Nekoua MP","year":"2016","unstructured":"Nekoua MP, Fachinan R, Atchamou AK, Nouatin O, Amoussouguenou D, Amoussouguenou MK, Moutairou K. Modulation of immune cells and Th1\/Th2 cytokines in insulin-treated type 2 diabetes mellitus. Afr Health Sci, 2016, 16:","journal-title":"Afr Health Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clim.2014.04.006","volume":"153","author":"Whitfieldlarry F","year":"2014","unstructured":"Whitfieldlarry F, Felton J, Buse J, Su MA. Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of type 1 diabetes mellitus patients. Clin Immunol, 2014, 153:","journal-title":"Clin Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.4049\/jimmunol.0903636","volume":"185","author":"Yin B","year":"2010","unstructured":"Yin B, Ma G, Yen CY, Zhou Z, Wang GX, Divino CM, Casares S. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol, 2010, 185: 5828-5834.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3851\/IMP1752","volume":"16","author":"Burke JD","year":"2011","unstructured":"Burke JD, Sonenberg N, Platanias LC, Fish EN. Antiviral effects of interferon-beta are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3. Antivir Ther, 2011, 16: 577-584.","journal-title":"Antivir Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.3892\/mmr.2015.3791","volume":"12","author":"Li H","year":"2015","unstructured":"Li H, Dai F, Peng Q, Gan H, Zheng J, Xia Y, Zhang W. Myeloid-derived suppressor cells suppress CD4+ and CD8+ T cell responses in autoimmune hepatitis. Mol Med Rep, 2015, 12:","journal-title":"Mol Med Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2009.06.014","volume":"9","author":"Ugel S","year":"2009","unstructured":"Ugel S, Delpozzo F, Desantis G, Papalini F, Simonato F, Sonda N, Zilio S. Therapeutic targeting of myeloid-derived suppressor cells. Curr Opin Pharmacol, 2009, 9: 470-481.","journal-title":"Curr Opin Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4049\/jimmunol.1101590","volume":"188","author":"Hu C","year":"2012","unstructured":"Hu C, Du W, Zhang X, Wong FS, Wen L. The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J Immunol, 2012, 188: 294-301.","journal-title":"J Immunol"},{"key":"null","first-page":"235","volume":"1","author":"Abdelrazaq AA","year":"2013","unstructured":"Abdelrazaq AA, Yousif WH, Wohaieb SA. Flow cytometric analysis of CD4 and CD8 T cell subsets in some Iraqi patients with diabetes mellitus type 2. Curr Res Microbiol Biotechnol, 2013, 1: 235-238.","journal-title":"Curr Res Microbiol Biotechnol"},{"key":"null","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","volume":"11","author":"Cripps JG","year":"2011","unstructured":"Cripps JG, Gorham JD. MDSC in autoimmunity. Int Immunopharmacol, 2011, 11: 789-793.","journal-title":"Int Immunopharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clim.2014.04.006","volume":"153","author":"Whitfield-Larry F","year":"2014","unstructured":"Whitfield-Larry F, Felton J, Buse J, Su MA. Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of type 1 diabetes mellitus patients. Clin Immunol, 2014, 153: 156-164.","journal-title":"Clin Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.lungcan.2013.06.005","volume":"81","author":"Heuvers ME","year":"2013","unstructured":"Heuvers ME, Muskens F, Bezemer K, Lambers M, Dingemans AM, Groen HJ, Smit EF. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients. Lung Cancer, 2013, 81: 468-474.","journal-title":"Lung Cancer"},{"key":"null","first-page":"506","volume":"39","author":"Yang B","year":"2012","unstructured":"Yang B, Yu J, Li H, Ren B, Liu J, An X, Liu T. Immunosuppressive impact of IDO on T cells in MDSCs of breast cancer. Chinese J Clin Oncol, 2012, 39: 506-509.","journal-title":"Chinese J Clin Oncol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/A04B1E4DAE9640228BF4B032DEA302C8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy014","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/A04B1E4DAE9640228BF4B032DEA302C8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T10:45:29Z","timestamp":1660387529000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,3,5]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmy014","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,1]]}}}